Mancilla Bethany 4
4 · Cue Biopharma, Inc. · Filed Mar 8, 2019
Insider Transaction Report
Form 4
Mancilla Bethany
SVP and Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-03-06+65,000→ 65,000 totalExercise: $6.42Exp: 2029-03-06→ Common Stock (65,000 underlying) - Award
Stock Option (right to buy)
2019-03-06+100,000→ 100,000 totalExercise: $9.54Exp: 2025-08-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.
- [F2]Represents a stock option award granted on August 1, 2018 that partially vested upon the achievement of certain performance based conditions as determined by the Compensation Committee of Cue Biopharma, Inc. on March 6, 2019. As of March 6, 2019, 50,000 of these options were vested and exercisable. The remaining 50,000 will become vested and exercisable only upon the achievement of certain performance based conditions.